Skip to main content
. 2020 Sep;9(9):5603–5613. doi: 10.21037/tcr-20-2634

Table 2. Comparison of Sox10 expression among different molecular subtypes of primary breast cancer and metastatic breast carcinoma.

Primary breast cancer Metastatic breast carcinoma
+ n + n
Luminal (A,B) 0 (0%) 240 (100%) 240 0 (0%) 44 (100%) 44
HER2 2 (3.1%) 63 (96.9%) 65 1 (9.1%) 10 (90.9%) 11
TNBC 48 (67.6%) 23 (32.4%) 71 15 (68.2%) 7 (31.8%) 22
n 50 110 376 16 61
χ2 359.047 71.263
P value <0.001 <0.001